Lombard Odier Asset Management USA Corp Sells 1,941 Shares of Cencora, Inc. $COR

Lombard Odier Asset Management USA Corp reduced its stake in Cencora, Inc. (NYSE:COR) by 31.8% in the first quarter, according to its most recent filing with the Securities and Exchange Commission. The fund owned 4,171 shares of the company’s stock after selling 1,941 shares during the quarter. Lombard Odier Asset Management USA Corp’s holdings in Cencora were worth $1,310,000 as of its most recent SEC filing.

Several other large investors have also bought and sold shares of COR. Kemnay Advisory Services Inc. purchased a new position in Cencora during the 4th quarter worth $25,000. Oakworth Capital Inc. purchased a new stake in shares of Cencora in the fourth quarter valued at about $26,000. Elyxium Wealth LLC purchased a new stake in shares of Cencora in the fourth quarter valued at about $27,000. Archer Investment Corp lifted its position in shares of Cencora by 134.3% during the fourth quarter. Archer Investment Corp now owns 82 shares of the company’s stock valued at $28,000 after purchasing an additional 47 shares in the last quarter. Finally, Motiv8 Investments LLC bought a new position in shares of Cencora during the fourth quarter valued at about $29,000. 97.52% of the stock is currently owned by institutional investors.

Wall Street Analysts Forecast Growth

COR has been the subject of a number of recent analyst reports. Morgan Stanley set a $342.00 price objective on shares of Cencora in a research report on Friday, May 8th. UBS Group lifted their target price on shares of Cencora from $410.00 to $412.00 and gave the stock a “buy” rating in a research report on Thursday, May 7th. Robert W. Baird cut their target price on Cencora from $420.00 to $339.00 and set an “outperform” rating on the stock in a research note on Thursday, May 7th. Barclays reduced their target price on Cencora from $425.00 to $350.00 and set an “overweight” rating for the company in a report on Wednesday, June 10th. Finally, Citigroup decreased their price target on Cencora from $405.00 to $355.00 and set a “buy” rating for the company in a research report on Thursday, May 7th. Eleven equities research analysts have rated the stock with a Buy rating and three have assigned a Hold rating to the stock. According to data from MarketBeat.com, Cencora has a consensus rating of “Moderate Buy” and a consensus target price of $367.75.

Cencora Price Performance

COR opened at $309.67 on Friday. The firm has a market cap of $60.25 billion, a P/E ratio of 23.75, a PEG ratio of 1.72 and a beta of 0.58. The firm has a 50-day moving average of $284.52 and a 200 day moving average of $316.47. The company has a debt-to-equity ratio of 3.40, a quick ratio of 0.59 and a current ratio of 0.95. Cencora, Inc. has a fifty-two week low of $244.82 and a fifty-two week high of $377.54.

Cencora (NYSE:COR) last posted its quarterly earnings data on Wednesday, May 6th. The company reported $4.75 earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of $4.82 by ($0.07). The company had revenue of $78.36 billion for the quarter, compared to analysts’ expectations of $81.09 billion. Cencora had a return on equity of 135.20% and a net margin of 0.78%.The business’s quarterly revenue was up 3.9% on a year-over-year basis. During the same quarter last year, the business posted $4.42 EPS. Cencora has set its FY 2026 guidance at 17.650-17.900 EPS. On average, research analysts expect that Cencora, Inc. will post 17.79 EPS for the current year.

Cencora Announces Dividend

The business also recently declared a quarterly dividend, which was paid on Monday, June 1st. Stockholders of record on Friday, May 15th were paid a dividend of $0.60 per share. The ex-dividend date was Friday, May 15th. This represents a $2.40 annualized dividend and a dividend yield of 0.8%. Cencora’s dividend payout ratio (DPR) is presently 18.40%.

Cencora announced that its board has initiated a share buyback program on Thursday, May 21st that permits the company to repurchase $2.00 billion in shares. This repurchase authorization permits the company to purchase up to 3.9% of its shares through open market purchases. Shares repurchase programs are typically a sign that the company’s board of directors believes its stock is undervalued.

Insider Activity at Cencora

In related news, Director Lauren M. Tyler purchased 550 shares of the stock in a transaction that occurred on Monday, June 22nd. The shares were bought at an average price of $270.23 per share, with a total value of $148,626.50. Following the acquisition, the director owned 4,359 shares of the company’s stock, valued at $1,177,932.57. This trade represents a 14.44% increase in their position. The purchase was disclosed in a filing with the SEC, which is accessible through this hyperlink. Company insiders own 0.38% of the company’s stock.

Cencora Company Profile

Cencora (NYSE:COR) is a global healthcare services and pharmaceutical distribution company that provides end-to-end solutions across the pharmaceutical supply chain. The company’s core activities include wholesale drug distribution, specialty drug distribution, and the operation of specialty pharmacies, complemented by logistics, cold-chain management and other fulfillment services designed to support complex and temperature-sensitive therapies.

Beyond physical distribution, Cencora offers a range of commercial and patient-focused services for pharmaceutical manufacturers and healthcare providers.